Kulicke and Soffa Industries, Inc.("Kulicke & Soffa," "K&S," "our," or the "Company"), today announced financial results of its second fiscal quarter ended April 4, 2026. The Company reported second quarter net revenue of $242.6 million, net income of $35.1 million, representing EPS of $0.66 per fully diluted share, and non-GAAP net income of $42.1 million, representing non-GAAP EPS of $0.79 per fully diluted share.

A reconciliation between the GAAP and non-GAAP adjusted results is provided in the financial tables included at the end of this press release. See also the "Use of non-GAAP Financial Results" section of this press release.
Lester Wong, Kulicke & Soffa's Interim Chief Executive Officer and Chief Financial Officer, stated, "Demand is stronger than anticipated due to both technology and capacity needs across general semiconductor, memory, automotive and industrial end markets. In addition to helping customers reach their production goals, we are also ramping near-term capital investment to support longer-term Advanced Solutions growth."
The Company anticipates fiscal year 2026 capital expenditure to increase sequentially from approximately $12 million to approximately $22 million. This incremental investment is expected to significantly expand the Company's production of its Thermo-Compression bonding ("TCB") systems, supporting up to approximately $400 million in annual TCB system sales.
Second Quarter Fiscal 2026 Financial Highlights
-
Net revenue of $242.6 million.
-
Gross margin of 49.3%.
-
Net income of $35.1 million or $0.66 per share; non-GAAP net income of $42.1 million or $0.79 per fully diluted share.
-
GAAP cash flow from operations of $10.3 million; Adjusted free cash flow of $6.3 million.
-
The Company repurchased a total of 3.0 thousand shares of common stock at a cost of $0.1 million.
Third Quarter Fiscal 2026 Outlook
K&S currently expects net revenue in the third quarter of fiscal 2026 ending July 4, 2026 to be approximately $310 million +/- $20 million, GAAP diluted EPS to be approximately $0.87 +/- 10%, and non-GAAP diluted EPS to be approximately $1.00 +/- 10%.